In conclusion, alterations in APN and APN receptors, which may be subtype specific to vulnerable brain regions and functional circuits involved in memory and executive function, namely the septohippocampal and basocortical systems, respectively, could represent novel targets for therapeutic intervention in DS and AD in the context of MetS/IR and T2DM. The gene discussed is ANPEP; the disease is Alzheimer disease.